Oncology Pharma Inc (ONPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2018 | 03-2007 | 03-2004 | 03-2003 | 03-2002 | |
| Sales | 0 | 0 | 0 | 3,280 | 3,670 |
| Cost of Goods | N/A | N/A | N/A | 1,210 | 1,350 |
| Gross Profit | N/A | N/A | 520 | 2,060 | 2,310 |
| Operating Expenses | 0 | 0 | 370 | 3,900 | 4,670 |
| Operating Income | N/A | N/A | -370 | -1,620 | -2,000 |
| Other Income | 0 | 0 | 0 | 100 | 50 |
| Pre-tax Income | 0 | 0 | -370 | -1,520 | -1,950 |
| Net Income Continuous | N/A | N/A | -1,565 | -1,520 | -1,951 |
| Net Income | $N/A | $N/A | $-1,565 | $-1,520 | $-1,950 |
| EPS Basic Total Ops | N/A | N/A | -70,000,000.00 | -79,999,990.00 | -12,000.00 |
| EPS Basic Continuous Ops | N/A | N/A | -70,000,000.00 | -79,999,990.00 | -12,006.15 |
| EPS Diluted Total Ops | N/A | N/A | -70,000,000.00 | -79,999,990.00 | -12,000.00 |
| EPS Diluted Continuous Ops | N/A | N/A | -70,000,000.00 | -79,999,990.00 | -12,006.15 |
| EBITDA(a) | $N/A | $N/A | $-290 | $-1,230 | $-1,660 |